FDA approves first flu vaccine that can be self-administered at home
By
HealthDay News
Sep 20, 2024
“For those interested in self or caregiver administration, the vaccine manufacturer plans to make the vaccine available through a third-party online pharmacy,” the FDA said. “Those who...
Wildfires are creating hazardous air conditions in western North America
Jul 26, 2024
During periods of unhealthy air, people should stay indoors with windows and doors closed.
Women undergoing CABG more likely to get care at low-quality hospitals
Jul 29, 2024
More than fourfold higher mortality was seen for women Medicare beneficiaries receiving coronary artery bypass grafting at low-quality hospitals than male beneficiaries at high-quality hospitals.
Two years later, 988 crisis line has answered 10 million requests
Jul 17, 2024
Statistics show the 988 line is needed: A 2022 national survey found that over 12 million adults had seriously considered suicide in the previous year. And almost 1.2 million of 988 calls were answered...
FDA grants full approval to Paxlovid to treat COVID-19
May 25, 2023
Paxlovid has been taken by older adults and others at high risk for severe COVID-19 under an emergency use approval.
FDA approves nivolumab as adjuvant treatment for melanoma
Oct 18, 2023
Approval was granted for patients aged 12 years and older with stage IIB/C disease.
Tougher federal penalties to come for failing nursing homes
Oct 24, 2022
New penalties will apply to fewer than 0.5 percent of U.S. nursing homes that are already designated as a ‘special focus facility’
US sets up $300 million database for Alzheimer’s disease research
Apr 05, 2023
In creating the database, the goal is to provide something that can “improve applicability and generalizability of findings.”
Jeanne Marrazzo will replace Fauci to lead National Institute of Allergy and Infectious Diseases
Aug 02, 2023
Marrazzo will start her new job in the fall.
Gabapentinoids linked to increased risk for severe exacerbation in COPD
Jan 16, 2024
Compared with matched nonusers, gabapentinoid users have an increased risk across indications of epilepsy, neuropathic pain and other chronic pain.